ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2014) 464 F.T.R. 66 (FC)
Linked as:
Extract
ViiV Healthcare ULC et al. v. Teva Canada Ltd. et al., (2014) 464 F.T.R. 66 (FC)
No longer available (Autolink)
See the full content of this document
This document cites
- Novartis Pharmaceuticals Canada Inc. v. Canada (Attorney General) et al., (2012) 415 F.T.R. 5 (FC)
- R. v. Prokofiew (E.), [2012] N.R. TBEd. OC.011
- Gilead Sciences Canada Inc. v. Canada (Minister of Health) et al., (2012) 435 N.R. 188 (FCA)
- Bristol-Myers Squibb Co. et al. v. Canada (Attorney General) et al., (2005) 334 N.R. 55 (SCC)
- Searle (G.D.) & Co. et al. v. Canada (Minister of Health), 2009 FCA 35
